fenofibrate has been researched along with Atrophy in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate treatment prevented arthritis-induced increase in atrogin-1 and MuRF1 expression in the gastrocnemius." | 5.37 | Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. ( Castillero, E; Fernández-Galaz, C; Granado, M; López-Calderón, A; López-Menduiña, M; Martín, AI; Nieto-Bona, MP; Villanúa, MA, 2011) |
| "Fenofibrate treatment prevented arthritis-induced increase in atrogin-1 and MuRF1 expression in the gastrocnemius." | 1.37 | Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. ( Castillero, E; Fernández-Galaz, C; Granado, M; López-Calderón, A; López-Menduiña, M; Martín, AI; Nieto-Bona, MP; Villanúa, MA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajima, H | 1 |
| Kai, Y | 1 |
| Fujimaki, J | 1 |
| Akashi, S | 1 |
| Morita, A | 1 |
| Ezaki, O | 1 |
| Kamei, Y | 1 |
| Miura, S | 1 |
| Castillero, E | 1 |
| Nieto-Bona, MP | 1 |
| Fernández-Galaz, C | 1 |
| Martín, AI | 1 |
| López-Menduiña, M | 1 |
| Granado, M | 1 |
| Villanúa, MA | 1 |
| López-Calderón, A | 1 |
2 other studies available for fenofibrate and Atrophy
| Article | Year |
|---|---|
Effects of fenofibrate and its combination with lovastatin on the expression of genes involved in skeletal muscle atrophy, including FoxO1 and its targets.
Topics: Animals; Atrophy; Drug Therapy, Combination; Fenofibrate; Forkhead Box Protein O1; Gene Expression; | 2021 |
Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.
Topics: Animals; Arthritis, Experimental; Atrophy; Body Weight; Eating; Fenofibrate; Gene Expression; Hypoli | 2011 |